首页> 外文OA文献 >Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50: Results of a Retrospective Study

【2h】

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50: Results of a Retrospective Study

机译：单独的Pembrolizumab或与高级NSCLC中的化疗结合PD-L1≥50％：回顾性研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ya Chen; Yanan Wang; Zhengyu Yang; Minjuan Hu; Yanwei Zhang; Fangfei Qian; Wei Zhang; Bo Zhang; Baohui Han;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P3.04-24 EMPOWER-Lung 2: Cemiplimab and Ipilimumab ± Chemotherapy vs Pembrolizumab in Advanced NSCLC with PD-L1 ≥50%, a Phase 3 Study [J] . N. Rizvi, S. Lee, P. Curtis, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P3.04-24 Empower-Lung 2：Cemimpab和Ipilimumab±化疗与Pembrolizumab在高级NSCLC中，PD-L1≥50％，一个第3期研究
2. PS3 KEYNOTE-024 Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC with PD-L1 Tumor Proportion Score ≥50% [J] . J. Brahmer, D. Rodríguez-Abreu, A. Robinson, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第9期

机译：PS3 Keynote-024更新：PEMBROLIZUAB与PD-L1肿瘤比例≥50％的PD-L1肿瘤比例≥50％
3. PS3 KEYNOTE-024 Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC with PD-L1 Tumor Proportion Score ≥50% [J] . J. Brahmer, D. Rodríguez-Abreu, A. Robinson, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第9期

机译：PS3 Keynote-024更新：PEMBROLIZUAB与PD-L1肿瘤比例≥50％的PD-L1肿瘤比例≥50％
4. Radio-Thermo-chemotherapy Comprehensive Treatment Advanced NSCLC [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：放化疗综合治疗晚期非小细胞肺癌
5. Clinical Comparison of Chemotherapy Regimens to Treat Advanced Retinoblastoma: Intra-Arterial and Intravitreal Chemotherapy Versus Intra-Arterial and Intravenous Chemotherapy [D] . Fine, Jessica. 2018

机译：化学疗法治疗晚期视网膜母细胞瘤的临床比较：动脉内和玻璃体内化疗与动脉内和静脉内化疗
6. Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50: Results of a Retrospective Study [O] . Ya Chen, Yanan Wang, Zhengyu Yang, 2021

机译：单独的Pembrolizumab或与高级NSCLC中的化疗结合PD-L1≥50％：回顾性研究的结果
7. OA 17.06 Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50 [O] . J. Brahmer, D. Rodríguez-Abreu, A. Robinson, 2017

机译：OA 17.06 keynote-024的更新分析：Pembrolizumab与PD-L1 TPS≥50％的高级NSCLC的铂基化疗

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50: Results of a Retrospective Study

著录项

引文网络

相似文献

相关主题

期刊订阅